Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AGX101 |
Synonyms | |
Therapy Description |
Limited information is currently available on AGX101, a putative antibody-drug conjugate (ADC) targeting TM4SF1 (Jun 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AGX101 | AGX-101|AGX 101 | Limited information is currently available on AGX101, a putative antibody-drug conjugate (ADC) targeting TM4SF1 (Jun 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06440005 | Phase I | AGX101 | A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors | Recruiting | USA | 0 |